Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ribon Therapeutics logo — Pioneering Therapeutics Targeting Cellular Stress Pathways

Ribon Therapeutics

Pioneering Therapeutics Targeting Cellular Stress Pathways

Founded 2015 United States Cambridge, United States 9 employees Series Unknown Total: $259.00M Biotechnology, Health Care

General Information

Company Name Ribon Therapeutics
Founded Year 2015
Location United States Cambridge, United States +1
Employees 9
Industries Biotechnology, Health Care
Funding Stage Series Unknown
Social

Get notified when Ribon Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ribon Therapeutics

Ribon Therapeutics is a biotechnology startup pioneering therapeutics targeting cellular stress pathways. Founded in 2015 and headquartered in the United States, Ribon is dedicated to discovering and developing first-in-class small molecule inhibitors designed to block the fundamental ability of cancer cells to survive under stress. Their most recent accomplishment includes a $25.00M Venture Round investment on 22 December 2022, with Pfizer Venture Investments as the lead investor. This strategic funding is expected to further drive the company's innovative approach to combating cancer through cellular stress pathway targeting therapeutics.

Taxonomy: clinical-stage, small molecule inhibitors, cancer cells, cellular stress pathways, PARP proteins, cancer medicines, drug discovery, monoPARPs, cancer treatment, molecular action, biology, proprietary drug discovery platform, life science investors, therapeutics

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 1 •••• •••• 22 Dec 2022
Debt Financing •••••• 1
Investor
26 Apr 2022
Series C •••••• 10
Investor Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		14 Jun 2021
Series B •••••• 9
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		04 Jan 2019
Venture Round •••••• - 10 Oct 2017

View All 7 Funding Rounds

Ribon Therapeutics Alternatives & Competitors

Ribon Therapeutics vs
Oncoheroes Biosciences
Oncoheroes Biosciences United States

Biotech Company 100% Focused on Pediatric Cancer Drug Development

Series Unknown
10 employees
Biotechnology
Ribon Therapeutics vs
VRise Therapeutics, Inc.
VRise Therapeutics, Inc. United States

A Precision Oncology Company

5 employees
Biopharma, Biotechnology
Ribon Therapeutics vs
Exelixis
Exelixis United States

Exelixis works on discovering, developing, and commercializing therapies for the treatment of cancer

IPO
1566 employees
Biotechnology

FAQ About Ribon Therapeutics

Pioneering Therapeutics Targeting Cellular Stress Pathways
Ribon Therapeutics was founded in 2015.
Ribon Therapeutics is headquartered in Cambridge, United States.
Ribon Therapeutics operates in the following industries: Biotechnology, Health Care.
Ribon Therapeutics has approximately 9 employees.
Ribon Therapeutics has completed 7 funding rounds, raising a total of $259.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Ribon Therapeutics include Oncoheroes Biosciences, VRise Therapeutics, Inc., Exelixis, NewBiotics, TRIO Pharmaceuticals, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ribon Therapeutics and Oncoheroes Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ribon Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy